SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

Search

Ratos AB (Class B)

Fermé

32.5 -0.37

Résumé

Variation du prix de l'action

24h

Actuel

Min

32.38

Max

33.42

Chiffres clés

By Trading Economics

Revenu

-2.1B

-1.7B

Ventes

436M

4.6B

P/E

Moyenne du Secteur

11.333

55.155

BPA

0.37

Rendement du dividende

3.87

Marge bénéficiaire

-37.883

Employés

8,591

EBITDA

-870M

136M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.87%

4.95%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

17M

12B

Ouverture précédente

32.87

Clôture précédente

32.5

Ratos AB (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 avr. 2026, 23:17 UTC

Résultats

Samsung Forecasts Record First-Quarter Operating Profit

6 avr. 2026, 23:00 UTC

Actions en Tendance

Stocks to Watch: Health Insurers, Mawson, Owlet

6 avr. 2026, 22:13 UTC

Principaux Mouvements du Marché

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 avr. 2026, 21:46 UTC

Acquisitions, Fusions, Rachats

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 avr. 2026, 17:09 UTC

Principaux Mouvements du Marché

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 avr. 2026, 16:56 UTC

Principaux Événements d'Actualité

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 avr. 2026, 14:47 UTC

Principaux Mouvements du Marché

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 avr. 2026, 23:58 UTC

Market Talk
Principaux Événements d'Actualité

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 avr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 avr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 avr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 avr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 avr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 avr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 avr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 avr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 avr. 2026, 18:36 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 17:59 UTC

Market Talk
Principaux Événements d'Actualité

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 avr. 2026, 17:13 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 avr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 avr. 2026, 14:59 UTC

Résultats

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparaison

Variation de prix

Ratos AB (Class B) prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Ratos AB (Class B)

Ratos AB (publ) is a private equity firm specializing in buyouts, turnarounds, add on acquisitions, and middle market transactions. The firm does not invest in early stages and in companies that operate in the arms industry, pornography, or are detrimental to the environment. It seeks to invest in unlisted medium sized companies. The firm invests in industry, construction and services, consumer, and technology sectors. The firm typically invests in the Nordic region, with focus on Sweden, Finland, Denmark, and Norway. It seeks to invest in companies with equity investments between SEK250 million ($23.57 million) and SEK5000 million ($471.57 million), sales value between SEK300 million ($28.29 million) and SEK5000 million ($471.57 million) and EBITDA greater than SEK50 million ($4.71 million). The firm takes both minority and majority stakes. The firm prefers to be the principal owner with a minimum holding of at least 20 percent and also seeks a board seat. It prefers to hold its investment between five to ten years. Ratos AB (publ) was founded in 1934 and is based in Stockholm, Sweden.
help-icon Live chat